Bortezomib & Plasma cell myeloma
14.5%
of users reported Plasma cell myeloma
91.5%
also reported Severe reaction
60.3%
are men
Most common medical consequences
Severe reaction
91.5%
Death
6.5%
Hospitalization
1.6%
Life-threatening condition
0.4%
Have you experienced any negative side effects from this medication?
Bortezomib: general information
Most common side effects (143)
Most commonly affected ages
0 - 9 years
0.5%
10 - 19 years
1.1%
20 - 29 years
0.4%
30 - 39 years
2.5%
40 - 49 years
6.6%
50 - 59 years
19.5%
60 - 69 years
32.9%
70 - 79 years
31.2%
80 - 89 years
5.3%
Stay safe!
Get the latest drug safety information, personalized and delivered straight to your inbox